An intraaortic solution trial to prevent spinal cord injury in a rabbit model

dc.contributor.authorTetik, Ö
dc.contributor.authorIslamoglu, F
dc.contributor.authorYagdi, T
dc.contributor.authorAtay, Y
dc.contributor.authorÇalkavur, T
dc.contributor.authorÖzbek, C
dc.contributor.authorVüksel, M
dc.date.accessioned2026-08-12T17:41:20Z
dc.date.issued2001
dc.departmentFırat Üniversitesi
dc.description49th International Congress of the European-Society-for-Cardiovascular-Surgery -- JUN 24-27, 2000 -- Dresden, GERMANY
dc.description.abstractObjectives: to evaluate the effectiveness of an intraaortic delivered solution on preventing spinal cord injury. Design:forty rabbits were allocated into five equal groups. Materials and Methods: one clamp was placed just distal to the left renal artery, and another was placed just above the iliac bifurcation for 40 min. Group I was not infused (control group). Through a 24G vascular catheter inserted into the isolated aortic segment, 20 nd of LR solution at room temperature (Group 2) 20 ml of LR solution at 3 degreesC (Group 3), and 20 ml of LR solution at 3 degreesC containing 30 mg/kg of methylprednisolone (Group 4) were infused over 3 min. In Group 5, 10mg/kg of vitamins E and C were delivered two days before the experiment, and 20ml of LR solution at 3 degreesC containing 30 mg/kg of methylprednisolone, and 10 mg/kg of vitamins E and C was infused at the operation. Postoperative spinal cord function was assessed using Tarlov's criteria. Results: the neurologic status of Groups 3, 4, and 5 was significantly superior to that of Groups I and 2. No paraplegia was observed in Groups 4 and 5. Spastic paraplegia occurred in all rabbits of Groups I and 2, and in 20% of Group 3. In the electron microscopic evaluation of spinal cord specimens, normal histologic structure was observed in Groups 4 and 5, whereas, some derangements were observed in all others. Conclusions: intraaortic infusion of a hypothermic blended solution containing methylprednisolone, vitamins C and E provided best protection against postischaemic spinal cord dysfunction.
dc.description.sponsorshipEuropean Soc Cardiovasc Surg
dc.identifier.doi10.1053/ejvs.2001.1428
dc.identifier.endpage179
dc.identifier.issn1078-5884
dc.identifier.issn1532-2165
dc.identifier.issue2
dc.identifier.orcid0000-0001-6282-2489
dc.identifier.pmid11472054
dc.identifier.scopus2-s2.0-0034909307
dc.identifier.scopusqualityQ1
dc.identifier.startpage175
dc.identifier.urihttps://doi.org/10.1053/ejvs.2001.1428
dc.identifier.urihttps://hdl.handle.net/11508/59291
dc.identifier.volume22
dc.identifier.wosWOS:000170379700014
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherW B Saunders Co Ltd
dc.relation.ispartofEuropean Journal of Vascular and Endovascular Surgery
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectspinal cord protection
dc.subjectparaplegia
dc.subjectischaemic injury
dc.titleAn intraaortic solution trial to prevent spinal cord injury in a rabbit model
dc.typeConference Object

Dosyalar